Tests a personalized plan to help people with sleep apnea keep using their treatment
Tests a personalized program helping adults with sleep apnea stick to their breathing device.
Key facts
- Who runs it
- University of Miami
- Where
- Miami, United StatesSee the site
- Trial code
- Registry title
- Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
- Status
- Recruiting
- People taking part
- 330 people, planned
- Started
- 19 Mar 2024
- Expected to end
- 31 May 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Standard of Care
- Personalized OSA Treatment
- Record updated
- 20 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for Black adults aged 55 to 85 with a diagnosis of obstructive sleep apnea (OSA). It tests a personalized program that helps people keep using their prescribed PAP treatment.
- Age
- 55 to 85 years
- Sex
- Men and women can both join.
- Disease stage
- A diagnosis of obstructive sleep apnea (OSA).
Main reasons for not taking part
- An illness that keeps getting worse, with disability or death expected within 1 year
- Memory, thinking or daily-function problems that prevent taking part
- Plans to move away within the year
- A family member who is already enrolled
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Self-reported race/ethnicity as African American, African, Afro-latino, Caribbean or black
- Ages 55-85 years
- accessible by phone
- OSA diagnosis
- consent, including permission to release medical data
Who cannot take part
- progressive illnesses in which disability or death is expected within 1 year
- impaired cognitive/ functional ability precluding participation
- intention to move within the year
- and a family member currently enrolled
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 55 and 85 years old?
Where in United States
- University of MiamiMiami, United StatesContact: Girardin Jean-Louis, PhDTaking people
About the trial
What the trial wants to find out
The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).
The 2 groups in the trial
- Standard of Care GroupExisting treatment, for comparison
Participants in this group receive the standard of care treatment for sleep apnea for up to six months.
Treatment: Standard of Care
- Personalized OSA Treatment GroupTreatment being tested
Participants in this group receive personalized OSA treatment for sleep apnea for up to six months.
Treatment: Standard of Care and Personalized OSA Treatment
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
- Plain-language title
- Tests a personalized plan to help people with sleep apnea keep using their treatmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06089161, who can take part
- Record updated
- 20 October 2026